RxDoctor Payments Data

Ashley Blackmon, NP

Nurse Practitioner · Atlanta, GANPI 1306107685

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,750 of the $13,123 with a category attached, or 74.3%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 83.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $7,174 and has fallen 97.3% since, to $196 in 2025. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,123in general payments, 2019–2025

Across 135 payments — averaging $97.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$11K
  • Novartis$707
  • Abbott$414
  • Kestra Medical Technology Services, Inc.$225
  • Sanofi$134
  • Abiomed$110
  • plus $638 from 13 others

What the payments were for

  • Speaking & faculty fees$9,75074%
  • Food & beverage$3,37326%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,123 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$3,881
Medicare patients
73
Services billed
77

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor31$22,926
Atorvastatin Calcium28$194
Nitroglycerin18$136
ClopidogrelClopidogrel Bisulfate17$134
Spironolactone30$110
Losartan Potassium15$81
Isosorbide Mononitrate ErIsosorbide Mononitrate11$70
Metoprolol Tartrate14$36
Lisinopril11$36
Furosemide25$29

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$87$22,92631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →